© 2020 MJH Life Sciences™ and Cancer Network. All rights reserved.
Hematology | Topics
Study of BMT-CARE Finds Coping, Self-Efficacy to Improve QOL, Mood in Caregivers of HSCT Recipients
October 23, 2020
According to researchers, this study suggests “that the improvements in QOL and mood experienced by caregivers assigned to BMT-CARE are, in part, explained by an acquisition of effective coping skills and confidence in their ability to provide care for their loved one.”
Patients with Hematologic Disease and Symptomatic COVID-19 Infection See Worse Prognosis
October 06, 2020
Patients with hematologic disease and a symptomatic COVID-19 infection were found to have a significantly worse prognosis than patients who were nonhematologic with COVID-19.
FDA Grants Breakthrough Therapy Designation to IMGN632 for BPDCN
October 05, 2020
The FDA granted breakthrough therapy designation to IMGN632 for the treatment of patients with relapsed or refractory blastic plasymacytoid dendritic cell neoplasm.